Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON BRIEFING: Kingfisher plans capital return despite cost pressure

23rd May 2022 08:18

(Alliance News) - Kingfisher on Monday said first-quarter sales were above pre-pandemic levels but had weakened year-on-year. The owner of the B&Q chain of DIY stores also unveiled a GBP300 million share buyback. Read More

LONDON MARKET MIDDAY: High inflation in UK and EU leaves stocks flat

18th May 2022 12:18

(Alliance News) - Europe's blue-chip stock benchmarks were drifting aimlessly at midday on Wednesday, as markets seemed unsure how to react to hot inflation figures in the UK and the eurozone. Read More

LONDON BROKER RATINGS: Kepler cuts Astra to hold; RBC raises Reckitt

18th May 2022 10:34

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon: Read More

TOP NEWS: AstraZeneca wins license to make and sell Covid antibodies

17th May 2022 09:12

(Alliance News) - AstraZeneca PLC on Tuesday said it signed a license agreement with RQ Biotechnology Ltd to develop, manufacture and sell Covid antibodies worldwide. Read More

AstraZeneca's PTO27 shows positive results in people with asthma

16th May 2022 14:34

(Alliance News) - AstraZeneca PLC on Sunday said its rescue medication candidate PTO27 showed positive results in its Mandala Phase III trial. Read More

NetScientific shares jump after "impressive" results of Covid-19 test

16th May 2022 12:16

(AllianceNews) - NetScientific PLC on Monday said its subsidiary ProAxsis Ltd had successfully completed the development and evaluation of an AstraZeneca PLC Covid-19 antibody test with "impressive" results. Read More

AstraZeneca's Enhertu approved in US, results for Farxiga, Ultomiris

5th May 2022 09:39

(Alliance News) - AstraZeneca PLC on Thursday reported several positive developments in its pipeline, including its breast cancer drug clearing another regulatory hurdle, and positive phase III trial results for Farxiga and Ultomiris. Read More

AstraZeneca's Imfinzi granted US priority review for bile duct cancer

4th May 2022 09:19

(Alliance News) - AstraZeneca PLC on Wednesday said its checkpoint inhibitor drug Imfinzi, generically durvalumab, has been granted priority review by the US Food & Drug Administration. Read More

LONDON BRIEFING: JD Wetherspoon blames lockdowns for inflation crisis

4th May 2022 08:23

(Alliance News) - JD Wetherspoon on Wednesday said sales improved steadily since the ending of all Covid restrictions, but the pub chain said virus woes have been replaced by "considerable pressure on costs" as a new source of concern. Read More

LONDON MARKET CLOSE: Stocks end volatile April on high note

29th Apr 2022 17:01

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed. Read More

TOP NEWS: AstraZeneca backs yearly outlook but quarterly profit down

29th Apr 2022 10:18

(Alliance News) - AstraZeneca PLC on Friday reported a sharp rise in first-quarter revenue, though profit declined, and the drugmaker also announced plans for a new strategic site in the US. Read More

LONDON MARKET PRE-OPEN: Strong Reckitt guidance; NatWest backs outlook

29th Apr 2022 07:50

(Alliance News) - Stock prices in London are seen opening higher on Friday, making a confident end to a tricky month for markets, which have faced Covid-19 worries in China, alongside rampant inflation and central bank monetary tightening in response. Read More

AstraZeneca wins US approval for generalised myasthenia gravis drug

28th Apr 2022 09:51

(Alliance News) - AstraZeneca PLC on Thursday said its drug Ultomiris has been approved by the US Food & Drug Administration for the treatment of adults with generalised myasthenia gravis. Read More

AstraZeneca, Daiichi Sankyo cancer drug secures US regulatory boost

27th Apr 2022 09:44

(Alliance News) - AstraZeneca PLC on Wednesday said a cancer drug it has helped develop to treat a form of breast cancer has been granted breakthrough therapy designation in the US. Read More

AstraZeneca's Tremelimumab-Imfinzi combo to get US priority review

25th Apr 2022 08:32

(Alliance News) - AstraZeneca PLC on Monday announced its candidate for unresectable liver cancer Tremelimumab has been accepted under priority review by the US Food & Drug Administration. Read More

LONDON MARKET PRE-OPEN: British Land sells Paddington Central stake

25th Apr 2022 07:50

(Alliance News) - Stock prices in Europe are seen opening lower on Monday, with a grim Covid-19 situation in China adding to a mountain of worries for equities investors, which included hawkish comments made by Federal Reserve Chair Jerome Powell late last week. Read More

FTSE 100 Latest

Value10,126.78

Change-68.57